Filter
795
Text search:
vaccine
trial
Featured
Recommendations
91
New Publications
168
Language
Document type
No document type
360
Studies & Reports
152
Guidelines
140
Fact sheets
39
Manuals
38
Strategic & Response Plan
25
Training Material
13
Situation Updates
11
Resource Platforms
10
Videos
4
Brochures
1
App
1
Infographics
1
Countries / Regions
Global
33
India
28
Sierra Leone
18
Kenya
17
South Africa
17
Liberia
13
West and Central Africa
13
Western and Central Europe
13
Uganda
12
Brazil
12
East and Southern Africa
11
Africa
10
Russia
10
Ethiopia
9
Eastern Europe
9
Nigeria
8
Ghana
8
Philippines
7
South Sudan
7
Latin America and the Carribbean
7
Guinea
6
Congo, Democratic Republic of
6
Zimbabwe
6
Zambia
6
Rwanda
6
Nepal
5
Tanzania
5
Bangladesh
5
Middle East and North Africa
5
Germany
4
Malawi
4
Mozambique
4
Ukraine
4
Myanmar / Burma
4
Syria
3
Cambodia
3
Paraguay
3
Asia
3
USA
2
Jordan
2
Lebanon
2
Thailand
2
Indonesia
2
Argentina
2
Namibia
2
Angola
2
Lesotho
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Burkina Faso
1
Guinea-Bissau
1
Cameroon
1
Haiti
1
Pakistan
1
Iraq
1
Turkey
1
Gambia
1
China
1
Papua New Guinea
1
Sudan
1
Honduras
1
Ecuador
1
Botswana
1
Chile
1
Yemen
1
Western Pacific Region
1
Venezuela
1
Southern Africa
1
Laos
1
Vietnam
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
202
Clinical Guidelines
110
Women & Child Health
55
Public Health
37
Key Resources
11
Pharmacy & Technologies
8
Capacity Building
2
Toolboxes
COVID-19
196
TB
73
HIV
64
Ebola
47
Rapid Response
33
NTDs
31
AMR
20
Pharmacy
15
Mental Health
13
Planetary Health
11
Global Health Education
10
NCDs
10
Cholera
9
Health Financing Toolbox
9
Refugee
8
Polio
7
Zika
6
Caregiver
6
Conflict
5
Disability
2
Natural Hazards
1
Este documento de referência foi preparado pelo Grupo de Trabalho sobre Vacinas contra COVID-19 do Grupo Consultivo Estratégico de Especialistas em Imunização (SAGE) para orientar as discussões do SAGE em sua reunião extraordinária de 8 de fevereiro de 2021, que resultou na publicação do do
...
3 March 2022
The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an
...
The internationally recognized criteria for diagnosis of neurocysticercosis include a requirement for neuroimaging techniques, such as computerized tomography (CT) and/or magnetic resonance imaging (MRI), ideally supported by serology. These facilities are not available in all settings, especially i
...
The Compendium of data and evidence-related tools for use in TB planning and programming was developed as a companion document to the People-centred framework for tuberculosis programme planning and prioritization – user guide, published by the World Health Organization (WHO)
...
Orientations provisoires 19 juillet 2021
More than two years since the first SARS-CoV-2 infections were reported, the COVID-19 pandemic remains an acute global emergency. In this Strategic Preparedness, Readiness and Response plan for 2022, WHO sets out a number of key strategic adjustments that, if implemented rapidly and consistently at
...
Resource platform
Esta orientação provisória foi desenvolvida com base na recomendação emitida pelo Grupo Consultivo Estratégico de Especialistas (SAGE) em imunização, em sua reunião extraordinária de 5 de janeiro de 2021, e atualizada durante sua reunião extraordinária de 27 de maio de 2021 (2), sendo no
...
Why bold action against inequalities is needed to en AIDS, stop COVID-19 and prepare for future pandemics
The WHO End TB Strategy aims to end the global TB epidemic by 2030, in alignment with Goal 3 of the United Nations (UN) Sustainable Development Goals (SDGs). Member States of the World Health Organization (WHO) and the UN committed to ending the TB epidemic through adoption of WHO’s End TB Strateg
...
Updated Treatment Guidelines
The purpose of this document is to provide relevant information and guidelines on
coronavirus outbreaks – and in particular the novel coronavirus SARS-CoV-2 and the
diseases it produces, COVID-19 – for pharmacists and the pharmacy workforce, both in a
primary care context (i.e. community phar
...
his guidance provides interim guidance for the integration of SARS-CoV-2 and influenza virologic and genomic surveillance, from sentinel site case enrolment and sampling to the eventual sharing of the virus sequence data, a process known as end-to-end surveillance. This guidance builds on experience
...
The role of community health workers in the vaccination against COVID-19: guide to support the implementation of the vaccination programme
Guidance for clinical case management of thrombosis syndrome with thrombocytopenia (TTS) following vaccination to prevent coronavirus disease (COVID-19)
Interim guidance 19 July 2021
This policy brief aims to provide a review of the current progress on implementing the Burkina Faso national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implemen
...
Drug registration in Kenya started in 1982; the process mainly involves an evaluation committee at the Kenya Pharmacy and Poisons Board (PPB) that aims to approve products based on quality, safety and efficacy.
